2023
DOI: 10.3389/fonc.2023.1173266
|View full text |Cite
|
Sign up to set email alerts
|

An oxidative stress biomarkers predict prognosis in gastric cancer patients receiving immune checkpoint inhibitor

Abstract: ObjectiveThe development and advance of gastric cancer are inextricably linked to oxidative and antioxidant imbalance. Although immunotherapy has been shown to be clinically effective, the link between oxidative stress and gastric cancer patients treated with immune checkpoint inhibitor (ICIs) remains unknown. This study aims at looking into the prognostic value of oxidative stress scores in gastric cancer patients treated with ICIs.MethodsBy taking the propagation to receiver operating characteristic (ROC) we… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 48 publications
0
1
0
Order By: Relevance
“…When GC patients are receiving treatment with an ICI, the development of sarcopenia or myosteatosis is a good indicator of how well they will fare clinically [ 62 ]. Furthermore, patient prognosis can be predicted using high and low values of the GC-Integrated Oxidative Stress Score (GIOSS), a biomarker reflecting systemic oxidative stress in the body [ 63 ].…”
Section: Other Factorsmentioning
confidence: 99%
“…When GC patients are receiving treatment with an ICI, the development of sarcopenia or myosteatosis is a good indicator of how well they will fare clinically [ 62 ]. Furthermore, patient prognosis can be predicted using high and low values of the GC-Integrated Oxidative Stress Score (GIOSS), a biomarker reflecting systemic oxidative stress in the body [ 63 ].…”
Section: Other Factorsmentioning
confidence: 99%